Cargando…
Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership
BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512411/ https://www.ncbi.nlm.nih.gov/pubmed/36127155 http://dx.doi.org/10.3399/BJGP.2022.0110 |
_version_ | 1784797838592442368 |
---|---|
author | Lynch, Charlotte Harrison, Samantha Emery, Jon D Clelland, Cathy Dorman, Laurence Collins, Claire Johansen, May-Lill Lawrenson, Ross Surgey, Alun Weller, David Jarbøl, Dorte Ejg Balasubramaniam, Kirubakaran Nicholson, Brian D |
author_facet | Lynch, Charlotte Harrison, Samantha Emery, Jon D Clelland, Cathy Dorman, Laurence Collins, Claire Johansen, May-Lill Lawrenson, Ross Surgey, Alun Weller, David Jarbøl, Dorte Ejg Balasubramaniam, Kirubakaran Nicholson, Brian D |
author_sort | Lynch, Charlotte |
collection | PubMed |
description | BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investigation contribute to differences in the timeliness of diagnoses and cancer outcomes in different countries. AIM: To explore the variation in primary care referral pathways for the management of suspected cancer across different countries. DESIGN AND SETTING: Descriptive comparative analysis using mixed methods across the International Cancer Benchmarking Partnership (ICBP) countries. METHOD: Schematics of primary care referral pathways were developed across 10 ICBP jurisdictions. The schematics were initially developed using the Aarhus statement (a resource providing greater insight and precision into early cancer diagnosis research) and were further supplemented with expert insights through consulting leading experts in primary care and cancer, existing ICBP data, a focused review of existing evidence on the management of suspected cancer, published primary care cancer guidelines, and evaluations of referral tools and initiatives in primary care. RESULTS: Referral pathway schematics for 10 ICBP jurisdictions were presented alongside a descriptive comparison of the organisation of primary care management of suspected cancer. Several key areas of variation across countries were identified: inflexibility of referral pathways, lack of a managed route for non-specific symptoms, primary care practitioner decision-making autonomy, direct access to investigations, and use of emergency routes. CONCLUSION: Analysing the differences in referral processes can prompt further research to better understand the impact of variation on the timeliness of diagnoses and cancer outcomes. Studying these schematics in local contexts may help to identify opportunities to improve care and facilitate discussions on what may constitute best referral practice. |
format | Online Article Text |
id | pubmed-9512411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Royal College of General Practitioners |
record_format | MEDLINE/PubMed |
spelling | pubmed-95124112022-10-21 Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership Lynch, Charlotte Harrison, Samantha Emery, Jon D Clelland, Cathy Dorman, Laurence Collins, Claire Johansen, May-Lill Lawrenson, Ross Surgey, Alun Weller, David Jarbøl, Dorte Ejg Balasubramaniam, Kirubakaran Nicholson, Brian D Br J Gen Pract Research BACKGROUND: International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investigation contribute to differences in the timeliness of diagnoses and cancer outcomes in different countries. AIM: To explore the variation in primary care referral pathways for the management of suspected cancer across different countries. DESIGN AND SETTING: Descriptive comparative analysis using mixed methods across the International Cancer Benchmarking Partnership (ICBP) countries. METHOD: Schematics of primary care referral pathways were developed across 10 ICBP jurisdictions. The schematics were initially developed using the Aarhus statement (a resource providing greater insight and precision into early cancer diagnosis research) and were further supplemented with expert insights through consulting leading experts in primary care and cancer, existing ICBP data, a focused review of existing evidence on the management of suspected cancer, published primary care cancer guidelines, and evaluations of referral tools and initiatives in primary care. RESULTS: Referral pathway schematics for 10 ICBP jurisdictions were presented alongside a descriptive comparison of the organisation of primary care management of suspected cancer. Several key areas of variation across countries were identified: inflexibility of referral pathways, lack of a managed route for non-specific symptoms, primary care practitioner decision-making autonomy, direct access to investigations, and use of emergency routes. CONCLUSION: Analysing the differences in referral processes can prompt further research to better understand the impact of variation on the timeliness of diagnoses and cancer outcomes. Studying these schematics in local contexts may help to identify opportunities to improve care and facilitate discussions on what may constitute best referral practice. Royal College of General Practitioners 2022-09-21 /pmc/articles/PMC9512411/ /pubmed/36127155 http://dx.doi.org/10.3399/BJGP.2022.0110 Text en © The Authors https://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Research Lynch, Charlotte Harrison, Samantha Emery, Jon D Clelland, Cathy Dorman, Laurence Collins, Claire Johansen, May-Lill Lawrenson, Ross Surgey, Alun Weller, David Jarbøl, Dorte Ejg Balasubramaniam, Kirubakaran Nicholson, Brian D Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title | Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title_full | Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title_fullStr | Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title_full_unstemmed | Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title_short | Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership |
title_sort | variation in suspected cancer referral pathways in primary care: comparative analysis across the international benchmarking cancer partnership |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512411/ https://www.ncbi.nlm.nih.gov/pubmed/36127155 http://dx.doi.org/10.3399/BJGP.2022.0110 |
work_keys_str_mv | AT lynchcharlotte variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT harrisonsamantha variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT emeryjond variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT clellandcathy variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT dormanlaurence variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT collinsclaire variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT johansenmaylill variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT lawrensonross variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT surgeyalun variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT wellerdavid variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT jarbøldorteejg variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT balasubramaniamkirubakaran variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership AT nicholsonbriand variationinsuspectedcancerreferralpathwaysinprimarycarecomparativeanalysisacrosstheinternationalbenchmarkingcancerpartnership |